Deciphera Pharmaceuticals' Grant - II Round

Deciphera Pharmaceuticals raised a round of funding on July 18, 2011. Investors include Kansas Bioscience Authority.

Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients by tackling key mechanisms of drug resistance that limit the rate and/or durab…

Articles about Deciphera Pharmaceuticals' Grant - II Round: